Stocks
LadRx CorporationCYTR
OTCHealthcareBiotechnology$0.09-2.17%
A microcap biotechnology company focused on developing and licensing oncology therapeutics derived from earlier CytRx research programs. The firm historically concentrated on albumin-binding drug conjugates such as aldoxorubicin and has explored partnerships or asset sales tied to its clinical-stage...
Market Cap: $052W Range: $0.05 – $0.86
Congressional Interest in LadRx Corporation (CYTR)
1 member of Congress has disclosed 1 trade in LadRx Corporation (CYTR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CYTR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-31 | Roger W. Marshall | buy | $1K – $15K |